COVID‐19 pandemic‐related changes in utilization of telehealth and treatment overall for alcohol use problems
Alcoholism: Clinical and Experimental Research · 2022-12 · 46 (12) · 2280-2291
DOI: 10.1111/acer.14961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism: Clinical and Experimental Research, online erschienen am 17.12.2022. Verfasst von Vanessa A Palzes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Addiction and Mental Health Research, Division of Research, Kaiser Permanente Northern California, Oakland, California, USA. Hauptthemen laut MEDLINE: COVID-19, Alcoholism, Telemedicine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIDA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
During the COVID‐19 pandemic, specialty alcohol treatment transitioned rapidly to telehealth, which may have created barriers for some patients but increased access for others. This study evaluated the impact of the COVID‐19 pandemic on alcohol treatment utilization and potential disparities.
Methods
We analyzed electronic health record and claims data from Kaiser Permanente Northern California for adults with alcohol use problems (alcohol use disorder or unhealthy alcohol use diagnoses) during pre‐COVID‐19 (March to December 2019, n = 32,806) and COVID‐19 onset (March to December 2020, n = 26,763). Generalized estimating equation models were fit to examine pre‐COVID‐19 to COVID‐19 onset changes in alcohol treatment initiation, engagement, and retention (days in treatment). Heterogeneity in pre‐COVID‐19 to COVID‐19 onset changes in treatment utilization by age, race, and ethnicity; neighborhood deprivation index (NDI); and comorbid medical and psychiatric disorders were also examined.
Results
Treatment initiation increased during the COVID‐19 onset period (adjusted odds ratio [aOR] = 1.46; 95% CI = 1.41–1.52). The increases in odds of treatment initiation during the COVID‐19 onset period compared with the pre‐COVID period were largest among patients aged 18–34 years (aOR = 1.59; 95% CI = 1.48–1.71), those without medical conditions (aOR = 1.56; 95% CI = 1.49–1.65), and those without psychiatric disorders (aOR = 1.60; 95% CI = 1.51–1.69). Patients aged 18–34 years (aOR = 5.21; 95% CI = 4.67–5.81), those with the second highest NDIs (aOR = 4.63; 95% CI = 4.12–5.19), and those without medical (aOR = 4.34; 95% CI = 4.06–4.65) or psychiatric comorbidities (aOR = 4.48; 95% CI = 4.11–4.89) had the greatest increases in telehealth treatment initiation from pre‐COVID‐19 to COVID‐19 onset. Treatment engagement and retention also increased during COVID‐19 onset, with the greatest increase among patients aged 35–49 years who initiated treatment via telehealth (engagement: aOR = 2.33; 95% CI = 1.91–2.83; retention: adjusted mean difference [aMD] = 3.3 days; 95% CI = 2.6–4.1). We found no significant variation of changes in treatment utilization by race and ethnicity.
Conclusions
The transition to telehealth in this healthcare system may have attracted subgroups of individuals who have historically underutilized care for alcohol use problems, particularly younger and healthier adults, without exacerbating pre‐pandemic racial and ethnic disparities in treatment utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Addiction and Mental Health Research, Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
- Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.
- Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
- The Permanente Medical Group, Addiction Medicine and Recovery Services, Oakland, California, USA.
ORCID-Profile: Vanessa A Palzes
Förderung
- NIAAA NIH HHS
- NIDA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Palzes, V. A., Chi, F. W., Metz, V. E., Campbell, C., Corriveau, C., & Sterling, S. (2022). COVID‐19 pandemic‐related changes in utilization of telehealth and treatment overall for alcohol use problems. Alcoholism: Clinical and Experimental Research, 46(12), 2280-2291. https://doi.org/10.1111/acer.14961
Vancouver
Palzes VA, Chi FW, Metz VE, Campbell C, Corriveau C, Sterling S. COVID‐19 pandemic‐related changes in utilization of telehealth and treatment overall for alcohol use problems. Alcoholism: Clinical and Experimental Research. 2022;46(12):2280-2291. doi:10.1111/acer.14961
BibTeX
@article{Palzes2022,
author = {Palzes, Vanessa A and Chi, Felicia W and Metz, Verena E and Campbell, Cynthia and Corriveau, Caroline and Sterling, Stacy},
title = {COVID‐19 pandemic‐related changes in utilization of telehealth and treatment overall for alcohol use problems},
journal = {Alcoholism: Clinical and Experimental Research},
year = {2022},
volume = {46},
number = {12},
pages = {2280--2291},
doi = {10.1111/acer.14961}
}
EUVIMED